XML 35 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHAREHOLDERS' EQUITY (Tables) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Equity [Abstract]        
Schedule of Accumulated Other Comprehensive Income (Loss)  
A roll forward of the amounts included in accumulated other comprehensive loss, net of tax (in millions), is shown below for the three and nine months ended September 30, 2022:
Marketable SecuritiesEmployee Benefit PlanInterest Rate DerivativesTotal
Balance at June 30, 2022, net of tax effect of $98
$(64)$(251)$$(308)
Reclassifications into earnings, net of tax impact of $0
— 
Change in value, net of tax impact of $6
(28)— (23)
Balance at September 30, 2022, net of tax effect of $104
$(90)$(250)$12 $(328)
Balance at December 31, 2021, net of tax effect of $83
$(4)$(252)$(6)$(262)
Reclassifications into earnings, net of tax impact of $1
— 
Change in value, net of tax impact of $20
(92)— 18 (74)
Balance at September 30, 2022, net of tax effect of $104
$(90)$(250)$12 $(328)
   
Related to marketable securities $ (328) $ (328) $ (308) $ (262)
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax 3 8    
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax (23) $ (74)    
Schedule of Stockholders' Equity Note, Warrants or Rights   Total warrants outstanding are as follows as of September 30, 2022:
Number of warrants outstandingStrike Price
PSP 1928,126 31.61
CARES Act loan warrants427,080 31.61
PSP 2305,499 52.25
PSP 3221,812 66.39
Outstanding September 30, 20221,882,517 
   
Related to marketable securities $ (328) $ (328) $ (308) $ (262)